Table 1:
Characteristics of cancer patients according to transplant status*
| Characteristic | Cancer patients with prior transplant | Cancer patients without prior transplant | ||
|---|---|---|---|---|
| (n = 11,416) | (n=7,136,060) | |||
| n | % | n | % | |
| Sex | ||||
| Female | 3,596 | 31.5 | 3,336,109 | 46.8 |
| Male | 7,820 | 68.5 | 3,799,951 | 53.3 |
| Age at diagnosis (years) | ||||
| < 40 | 910 | 8.0 | 316,983 | 4.4 |
| 40–49 | 1,545 | 13.5 | 682,091 | 9.6 |
| 50–59 | 3,252 | 28.5 | 1,349,555 | 18.9 |
| 60–69 | 4,086 | 35.8 | 1,961,454 | 27.5 |
| 70–79 | 1,509 | 13.2 | 1,869,434 | 26.2 |
| 80+ | 114 | 1.0 | 956,543 | 13.4 |
| Race | ||||
| White | 8,286 | 72.6 | 5,856,905 | 82.1 |
| Black | 1,881 | 16.5 | 652,504 | 9.1 |
| Other | 1,249 | 10.9 | 626,651 | 8.8 |
| Cancer site | ||||
| Oral Cavity/pharynx | 696 | 6.1 | 213,384 | 3.0 |
| Colorectum | 942 | 8.3 | 1,011,114 | 14.2 |
| Esophagus | 140 | 1.2 | 86,465 | 1.2 |
| Stomach | 240 | 2.1 | 152,174 | 2.1 |
| Liver | 202 | 1.8 | 90,753 | 1.3 |
| Pancreas | 232 | 2.0 | 189,175 | 2.7 |
| Larynx | 170 | 1.5 | 82,874 | 1.2 |
| Lung | 1,910 | 16.7 | 1,131,970 | 15.9 |
| Melanoma | 552 | 4.8 | 333,779 | 4.7 |
| Breast | 858 | 7.5 | 1,473,944 | 20.7 |
| Prostate | 1,607 | 14.1 | 1,455,712 | 20.4 |
| Bladder | 350 | 3.1 | 236,360 | 3.3 |
| Kidney | 1,562 | 13.7 | 235,833 | 3.3 |
| Thyroid | 399 | 3.5 | 199,586 | 2.8 |
| DLBCL | 1,353 | 11.9 | 132,852 | 1.9 |
| Myeloma | 203 | 1.8 | 110,085 | 1.5 |
| Stage at diagnosis | ||||
| Local | 5,906 | 51.7 | 3,534,550 | 49.5 |
| Regional | 2,248 | 19.7 | 1,757,969 | 24.6 |
| Distant | 2,704 | 23.7 | 1,363,898 | 19.1 |
| Unknown | 558 | 4.9 | 479,643 | 6.7 |
| Year of diagnosis | ||||
| 1987–1996 | 1,061 | 9.3 | 2,148,823 | 30.1 |
| 1997–2001 | 2,204 | 19.3 | 1,551,233 | 21.7 |
| 2002–2005 | 2,533 | 22.2 | 1,280,815 | 18.0 |
| 2006–2009 | 3,304 | 28.9 | 1,360,411 | 19.1 |
| 2010–2014 | 2,314 | 20.3 | 794,778 | 11.1 |
| Surgical therapy† | ||||
| Yes | 6,055 | 57.8 | 3,654,689 | 61.3 |
| No | 4,158 | 39.7 | 2,140,106 | 35.9 |
| Unknown | 261 | 2.5 | 168,546 | 2.8 |
| Radiation therapy† | ||||
| Yes | 2,489 | 23.8 | 1,770,427 | 29.7 |
| No | 7,525 | 71.8 | 3,844,285 | 64.5 |
| Unknown | 460 | 4.4 | 348,629 | 5.9 |
| Chemotherapy† | ||||
| Yes | 2,663 | 25.4 | 1,514,814 | 25.4 |
| No | 7,296 | 69.7 | 4,114,024 | 69.0 |
| Unknown | 515 | 4.9 | 334,503 | 5.6 |
Abbreviations: DLBCL, diffuse large B-cell lymphoma
*
The cohort includes cancer cases from the following cancer registries that provided information on vital status and cause of death: California (years of cancer diagnosis and follow-up 1988–2012);Colorado (1988–2009);Connecticut (1987–2009);Georgia (1995–2010);Illinois (1987–2013);Iowa (1987–2009);Kentucky (1995–2011);New Jersey (1987–2010);Pennsylvania (1987–2013);Seattle (1987–2014);Texas (1995–2010).
†
Treatment information was available for all cancer registries for all calendar years of diagnosis, with the exception of Pennsylvania (data restricted to 1998–2013), Kentucky (2004–2011) and Illinois (2005–2013).